NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $26.28 +0.13 (+0.50%) Closing price 03:59 PM EasternExtended Trading$26.40 +0.12 (+0.47%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Guardian Pharmacy Services Stock (NYSE:GRDN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GRDN alerts:Sign Up Key Stats Today's Range$25.99▼$26.7050-Day Range$19.84▼$26.2852-Week Range$14.16▼$26.91Volume373,775 shsAverage Volume252,519 shsMarket Capitalization$1.66 billionP/E RatioN/ADividend YieldN/APrice Target$25.67Consensus RatingBuy Company Overview Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia. Read More Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreGRDN MarketRank™: Guardian Pharmacy Services scored higher than 11% of companies evaluated by MarketBeat, and ranked 912th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageGuardian Pharmacy Services has received no research coverage in the past 90 days.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-3.45% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to decrease by -3.45% in the coming year, from $0.87 to $0.84 per share.Price to Book Value per Share RatioGuardian Pharmacy Services has a P/B Ratio of 9.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Guardian Pharmacy Services' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GRDN. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GRDN. News and Social Media2.9 / 5News Sentiment1.20 News SentimentGuardian Pharmacy Services has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Guardian Pharmacy Services this week, compared to 3 articles on an average week.Search Interest1 people have searched for GRDN on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.Percentage Held by Insiders63.71% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRDN Stock News HeadlinesContrasting Guardian Pharmacy Services (GRDN) & Its RivalsAugust 24, 2025 | americanbankingnews.comWall Street Zen Upgrades Guardian Pharmacy Services (NYSE:GRDN) to "Strong-Buy"August 19, 2025 | americanbankingnews.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.August 29 at 2:00 AM | American Alternative (Ad)Guardian Pharmacy: Q2 Earnings SnapshotAugust 11, 2025 | finance.yahoo.comGuardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year GuidanceAugust 11, 2025 | businesswire.comGuardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of Oregon-based Managed Healthcare PharmacyAugust 4, 2025 | businesswire.comShould You Consider Adding Guardian Pharmacy Services (GRDN) to Your Portfolio?July 24, 2025 | msn.comGuardian Pharmacy Services, Inc. to Report Second Quarter 2025 Financial Results and Host Conference CallJuly 22, 2025 | businesswire.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $20.26 at the start of the year. Since then, GRDN shares have increased by 29.7% and is now trading at $26.2810. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced its quarterly earnings data on Monday, May, 12th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by $0.01. The company had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. Guardian Pharmacy Services had a negative net margin of 6.90% and a negative trailing twelve-month return on equity of 52.41%. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities acted as the underwriters for the IPO. Who are Guardian Pharmacy Services' major shareholders? Top institutional shareholders of Guardian Pharmacy Services include Brown Advisory Inc. (2.66%), Franklin Resources Inc. (1.54%), TimesSquare Capital Management LLC (1.29%) and New York State Common Retirement Fund (0.55%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, David K Morris, Kendall Forbes, John Ackerman and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardian Pharmacy Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META). Company Calendar Last Earnings5/12/2025Today8/29/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryRetail Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,400Year FoundedN/APrice Target and Rating Average Price Target for Guardian Pharmacy Services$25.67 High Price Target$28.00 Low Price Target$21.00 Potential Upside/Downside-2.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.52) Trailing P/E RatioN/A Forward P/E Ratio30.21 P/E GrowthN/ANet Income-$87.29 million Net Margins-6.90% Pretax Margin-4.80% Return on Equity-52.41% Return on Assets-24.17% Debt Debt-to-Equity RatioN/A Current Ratio1.18 Quick Ratio0.88 Sales & Book Value Annual Sales$1.33 billion Price / Sales1.25 Cash Flow$0.25 per share Price / Cash Flow103.27 Book Value$2.84 per share Price / Book9.25Miscellaneous Outstanding Shares63,321,000Free Float22,979,000Market Cap$1.66 billion OptionableN/A BetaN/A Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:GRDN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.